Radio and PodcastRadio and PodcastLive Radio & Podcasts
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) artwork
Science & Medicine

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)

FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research

Jul 27, 20224:00Science & Medicine

Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medici...

About This Episode

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Liste...

Podcast

This episode belongs to FDA Drug Safety Podcasts.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 27, 2022, 4:00 long, audio available.

Related Episodes

Continue listening to more episodes from FDA Drug Safety Podcasts.

Questions About This Episode

What is FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) about?

Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma.

Where can I listen to FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)?

You can listen to FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) from?

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research.

How long is this episode?

This episode is 4:00 long.

When was this episode published?

This episode was published on Jul 27, 2022.

Can I save FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from FDA Drug Safety Podcasts?

Yes. This page shows related episodes from FDA Drug Safety Podcasts when more episodes are available from the podcast feed.

Quick Answers About This Episode

Where can I listen to FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)?

You can listen to FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) on this page when the episode audio is available from the podcast feed.

Which podcast is this episode from?

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) is from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research.

What are the episode details?

Published Jul 27, 2022 and 4:00 long